微信小陈
微信小章
产品简介
购买须知
| 产品名称： | Streptomyces myxogenes |
|---|---|
| 商品货号： | TS173491 |
| Strain Designations： | SF-1130 FERM-P 676 |
| Application： | Produces antibiotic SF-1130-X1 SF-1130-X1 Produces antibiotic SF-1130-X2 SF-1130-X2 Produces maltohexaose Produces maltopentaose Produces oligostatin C antibiotic SF-1130-X3 |
| Isolation： | Soil, Japan |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Type Strain： | no |
| Medium： | ATCC® Medium 551: Oatmeal agar (ISP Medium 3) |
| Growth Conditions： | Temperature: 26.0°C |
| Name of Depositor： | Meiji Seika Kaisha, Ltd. |
| U.S. Patent Number： | |
| References： | Omoto S, et al. Process for production of maltopentaose and maltohexaose. US Patent 4,151,041 dated Apr 24 1979 Omoto S, et al. Antibiotics SF-1130-x1 and -x2 substances and production and use thereof. US Patent 4,160,026 dated Jul 3 1979 Itoh J, et al. Antibiotic SF-1130-x3 substance and production and use thereof. US Patent 4,316,894 dated Feb 23 1982 |